These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 6785666)
1. The market vs. regulation: the case for regulation. Vladeck BC Milbank Mem Fund Q Health Soc; 1981; 59(2):209-23. PubMed ID: 6785666 [No Abstract] [Full Text] [Related]
2. Cost reimbursement and price competition in the hospital industry. Milch RA Health Care Manage Rev; 1979; 4(2):53-6. PubMed ID: 10242150 [TBL] [Abstract][Full Text] [Related]
3. The health cost problem: is regulation our only hope? Helms RB Bull N Y Acad Med; 1980; 56(1):26-37. PubMed ID: 6766763 [No Abstract] [Full Text] [Related]
4. Health policy uses and usefulness of cost-benefit and cost-effectiveness analysis. Warner KE Mead Johnson Symp Perinat Dev Med; 1982; (20):53-69. PubMed ID: 6821470 [No Abstract] [Full Text] [Related]
5. Comparative health systems. The United States. Frech HE Adv Health Econ Health Serv Res Suppl; 1990; 1():43-75. PubMed ID: 10113795 [No Abstract] [Full Text] [Related]
7. Table manners at the health-care feast: 'regulation' vs. 'market'. Reinhardt UE Natl J (Wash); 1981 May; 13(19):855-61. PubMed ID: 10309395 [No Abstract] [Full Text] [Related]
8. Health care costs: why regulation fails, why competition works, how to get there from here. Enthoven AC Natl J (Wash); 1979 May; 11(21):885-9. PubMed ID: 10241582 [No Abstract] [Full Text] [Related]
9. Procompetition in health care: policy or fantasy? Ginzberg E Milbank Mem Fund Q Health Soc; 1982; 60(3):386-98. PubMed ID: 6985555 [No Abstract] [Full Text] [Related]
10. New congressional health leaders--the emphasis is on competition. Demkovich LE Natl J (Wash); 1980 Jul; 12(27):1093-7. PubMed ID: 10247441 [No Abstract] [Full Text] [Related]
11. The German health care system: a model for hospital reform in the United States? Weil TP Hosp Health Serv Adm; 1992; 37(4):533-47. PubMed ID: 10122372 [TBL] [Abstract][Full Text] [Related]
12. Competition and health cost containment: cautions and conjectures. Brown LD Milbank Mem Fund Q Health Soc; 1981; 59(2):145-89. PubMed ID: 6908948 [TBL] [Abstract][Full Text] [Related]
13. Free market role in medical care. Vandor T CMAJ; 1995 Mar; 152(5):655-6. PubMed ID: 7882226 [No Abstract] [Full Text] [Related]
14. Control of health-care costs in the 1980's. McNerney WJ N Engl J Med; 1980 Nov; 303(19):1088-95. PubMed ID: 6775224 [No Abstract] [Full Text] [Related]
15. State action as a shield and a sword in a medical services antitrust context: Parker v. Brown in constitutional perspective. Blumstein JF; Calvani T Duke Law J; 1978 May; (2):389-441. PubMed ID: 10239064 [No Abstract] [Full Text] [Related]
17. Antitrust laws and the health care industry: new warriors into an old battle. Rosoff AJ Spec Law Dig Health Care (Mon); 1979 Nov; (9):5-39. PubMed ID: 10295002 [No Abstract] [Full Text] [Related]
18. Governmental regulation of health care: a response to some criticisms voiced by proponents of a "free market". Weiner SM Am J Law Med; 1978; 4(1):15-33. PubMed ID: 685983 [TBL] [Abstract][Full Text] [Related]
19. Divide et impera: protecting the growth of health care incomes (COSTS). Reinhardt U Health Econ; 2012 Jan; 21(1):41-54. PubMed ID: 22147628 [No Abstract] [Full Text] [Related]
20. "Procompetition" and the continuing struggle to contain health-care costs. Enright SM Am J Hosp Pharm; 1983 Feb; 40(2):282-6. PubMed ID: 6829583 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]